Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2005-6-24
pubmed:abstractText
All patients undergoing heart surgery experience a certain amount of nonspecific myocardial injury documented by the release of cardiac biomarkers and associated with poor outcome. We investigated the role of unipolar radiofrequency ablation of atrial fibrillation on the release of cardiac biomarkers in 71 patients undergoing mitral valve surgery and concomitant left atrial ablation case-matched with 71 patients undergoing isolated mitral surgery. The study was powered to detect a 3 ng/mL difference. There was no difference between the 2 groups in terms of cardiac troponin I (10 +/- 5.3 versus 12 + 10.4 ng/mL; P = 0.7) or creatine kinase-MB (50 +/- 21.8 versus 57 +/- 62.0 ng/mL; P = 0.5) release. Postoperative peak cardiac troponin I levels had univariate associations with the duration of cardiopulmonary bypass (P = 0.002) and aortic cross-clamping (P = 0.001) and with the surgical technique (15 +/- 12 ng/mL for mitral valve replacement versus 9 +/- 4.8 for mitral valve repair; P = 0.0007) at univariate analysis. Mitral valve replacement was the only independent predictor of postoperative peak release of cardiac troponin I identified with multivariate analysis (P = 0.005). Radiofrequency ablation of atrial fibrillation does not significantly increase cardiac biomarker release compared with isolated mitral surgery; mitral valve repair is associated with less release of cardiac biomarkers compared with mitral valve replacement.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0003-2999
pubmed:author
pubmed:issnType
Print
pubmed:volume
101
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
24-9, table of contents
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed-meshheading:15976200-Aged, pubmed-meshheading:15976200-Biological Markers, pubmed-meshheading:15976200-Cardiac Surgical Procedures, pubmed-meshheading:15976200-Case-Control Studies, pubmed-meshheading:15976200-Catheter Ablation, pubmed-meshheading:15976200-Combined Modality Therapy, pubmed-meshheading:15976200-Creatine Kinase, pubmed-meshheading:15976200-Creatine Kinase, MB Form, pubmed-meshheading:15976200-Female, pubmed-meshheading:15976200-Heart Valve Prosthesis Implantation, pubmed-meshheading:15976200-Humans, pubmed-meshheading:15976200-Isoenzymes, pubmed-meshheading:15976200-Male, pubmed-meshheading:15976200-Middle Aged, pubmed-meshheading:15976200-Mitral Valve, pubmed-meshheading:15976200-Monitoring, Intraoperative, pubmed-meshheading:15976200-Myocardium, pubmed-meshheading:15976200-Necrosis, pubmed-meshheading:15976200-Postoperative Care, pubmed-meshheading:15976200-Treatment Outcome, pubmed-meshheading:15976200-Troponin I
pubmed:year
2005
pubmed:articleTitle
The effect of concomitant radiofrequency ablation and surgical technique (repair versus replacement) on release of cardiac biomarkers during mitral valve surgery.
pubmed:affiliation
Department of Cardiovascular Anesthesia, IRCCS San Raffaele Hospital, Milan, Italy, Via Olgettina 60, 20132 Milano Italy.
pubmed:publicationType
Journal Article